Does use of flue-cured rather than blended cigarettes affect international variation in mortality from lung cancer and COPD?

References

• Baker, R. R., Massey, E. D., and Smith, G. 2004. An overview of the effects of tobacco ingredients on smoke chemistry and toxicity. Food Chem. Toxicol. 42S:S53–S83.
   Web of Science ®Google Scholar
• Carmines, E. L. 2002. Evaluation of the potential effects of ingredients added to cigarettes. Part 1: Cigarette design, testing approach, and review of results. Food Chem. Toxicol. 40:77–91.
   PubMed Web of Science ®Google Scholar
• Forey, B., Hamling, J., Lee, P., and Wald, N., eds. 2002. International smoking statistics. A collection of historical data from 30 economically developed countries, 2nd ed. London and Oxford: Wolfson Institute of Preventive Medicine and Oxford University Press. Errata available at http://www.pnlee.co.uk/ISS2.htm.
   Google Scholar
• Forey, B., and Lee, P. 2002. Estimation of sex-specific smoking statistics by standardized age groups and time periods. Supplement 1 to International smoking statistics, A collection of historical data from 30 economically developed countries (2nd edition). Sutton, Surrey: P N Lee Statistics and Computing Ltd. http://www.pnlee.co.uk/reflist.htm [Download ISS2suppl1 FOREY2002C]
   Google Scholar
• Forey, B. A., Hamling, J., and Hamling, J. 2006. Deriving estimates of ex-smoking prevalence. Sutton, Surrey: P N Lee Statistics and Computing Ltd. http://www.pnlee.co.uk/reflist.htm [Download FOREY2006]
   Google Scholar
• Forey, B. A., Hamling, J., and Lee, P. N. 2007. International mortality and smoking statistics IMASS Version 4.02. Sutton, Surrey: P N Lee Statistics and Computing Ltd. http://www.pnlee.co.uk/IMASS.htm
   Google Scholar
• Friedman, G. D., Tekawa, I., Sadler, M., and Sidney, S. 1997. Smoking and mortality: the Kaiser Permanente experience. In Changes in cigarette-related disease risks and their implications for prevention and control, pp. 477–499. Smoking and Tobacco Control. Monograph No. 8, eds. Shopland D. R., D. M. Burns, L. Garfinkel, and Samet J. M.. (NIH Pub. No. 97-4213.) Rockville, MD: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute. http://cancercontrol.cancer.gov/tcrb/monographs/8/m8_6.pdf
   Google Scholar
• International Agency for Research on Cancer. 1976. Cancer incidence in five continents, Vol. III, eds. J. Waterhouse, C. Muir, P. Correa, and J. Powell. Lyon, France: IARC.
   Google Scholar
• Lange, P., Nyboe, J., Appleyard, M., Jensen, G., and Schnohr, P. 1992. Relationship of the type of tobacco and inhalation pattern to pulmonary and total mortality. Eur. Respir. J. 5:1111–1117.
   PubMed Web of Science ®Google Scholar
• Lee, P. N., and Forey, B. A. 2003. How do lung cancer rates in never smokers vary by country? P.N. Lee Statistics and Computing Ltd. http://www.pnlee.co.uk/reflist.htm [Download LEE2003O].
   Google Scholar
• Lee, P. N., and Forey, B. A. 2006. Indirectly estimated absolute lung cancer rates in ever smokers and never smokers by gender, region, year and histological type. P.N. Lee Statistics and Computing Ltd. http://www.pnlee.co.uk/reflist.htm [Download LEE2006M].
   Google Scholar
• Lee, P. N., Forey, B. A., and Young, K. J. 2003a. International evidence on smoking and lung cancer (project IESLC). A first report. Part I: The databases, methods used to collect and analyse the data and scope of the information obtained. P.N. Lee Statistics and Computing Ltd. http://www.pnlee.co.uk/reflist.htm [Download LEE2003J].
   Google Scholar
• Lee, P. N., Forey, B. A., and Young, K. J. 2003b. International evidence on smoking and lung cancer (project IESLC). A first report. Part II: Results of selected meta-analyses. P.N. Lee Statistics and Computing Ltd. http://www.pnlee.co.uk/reflist.htm [Download LEE2003K].
   Google Scholar
• Legg, P. D., and Smeeton, B. W. 1999. 2. Breeding and genetics. In Tobacco production, chemistry, and technology, eds. D. L. Davis, and M. T. Nielson, pp. 32–48. Oxford: Blackwell Science.
   Google Scholar
• Lemus, R., Carmines, E. L., Van Miert, E., Coggins, C. R. E., Anskeit, E., Gerstenberg, B., Meisgen, T. J., Schramke, H., Stabbert, R., Völkel, H., and Terpstra, P. M. 2007. Toxicological comparisons of cigarettes containing different amounts of vanillin. Inhal. Toxicol. 19:683–699.
   PubMed Web of Science ®Google Scholar
• Pauwels, R. A., and Rabe, K. F. 2004. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 364:613–620.
   PubMed Web of Science ®Google Scholar
• Peto, R., Darby, S., Deo, H., Silcocks, P., Whitley, E., and Doll, R. 2000. Smoking, smoking cessation, and lung cancer in the UK since 1950: Combination of national statistics with two case-control studies. Br. Med. J. 321:323–329.
   PubMed Web of Science ®Google Scholar
• Renne, R. A., Yoshimura, H., Yoshino, K., Lulham, G., Minamisawa, S., Tribukait, A., Dietz, D. D., Lee, K. M., and Westerberg, R. B. 2006. Effects of flavoring and casing ingredients on the toxicity of mainstream cigarette smoke in rats. Inhal. Toxicol. 18:685–706.
   PubMed Web of Science ®Google Scholar
• Roemer, E., Stabbert, R., Rustemeier, K., Veltel, D. J., Meisgen, T. J., Reininghaus, W., Carchman, R. A., Gaworski, C. L., and Podraza, K. F. 2004. Chemical composition, cytotoxicity and mutagenicity of smoke from US commercial and reference cigarettes smoked under two sets of machine smoking conditions. Toxicology 195:31–52.
   PubMed Web of Science ®Google Scholar
• Roemer, E., Tewes, F. J., Meisgen, T. L., Veltel, D. J., and Carmines, E. L. 2002. Evaluation of the potential effects of ingredients added to cigarettes. Part 3: In vitro genotoxicity and cytotoxicity. Food Chem. Toxicol. 40:105–111.
   PubMed Web of Science ®Google Scholar
• Romieu, I., and Trenga, C. 2001. Diet and obstructive lung diseases. Epidemiol. Rev. 23:268–287.
   PubMed Web of Science ®Google Scholar
• Rustemeier, K., Stabbert, R., Haussmann, H. -J., Roemer, E., and Carmines, E. L. 2002. Evaluation of the potential effects of ingredients added to cigarettes. Part 2: Chemical composition of mainstream smoke. Food Chem. Toxicol. 40:93–104.
   PubMed Web of Science ®Google Scholar
• Schramke, H., Meisgen, T. J., Tewes, F. J., Gomm, W., and Roemer, E. 2006. The mouse lymphoma thymidine kinase assay for the assessment and comparison of the mutagenic activity of cigarette mainstream smoke particulate phase. Toxicology 227:193–210.
   PubMed Web of Science ®Google Scholar
• Select Committee on Health of the UK Houses of Parliament. 2000. Second report of the Select Committee on Health of the UK Houses of Parliament, “The tobacco industry and the health risks of smoking.” Appendices to the Minutes of Evidence.
   Google Scholar
• Speizer, F. E., Fay, M. E., Dockery, D. W., and Ferris, B. G., Jr., 1989. Chronic obstructive pulmonary disease mortality in six US cities. Am. J. Respir. Crit. Care Med. 140:S49–S55.
   PubMed Web of Science ®Google Scholar
• Sterling, T. D., Rosenbaum, W. L., and Weinkam, J. J. 1993. Risk attribution and tobacco-related deaths. Am. J. Epidemiol. 138:128–139.
   PubMedGoogle Scholar
• Talhout, R., Opperhuizen, A., and van Amsterdam, J. G. C. 2006. Sugars as tobacco ingredient: Effects on mainstream smoke composition. Food Chem. Toxicol. 44:1789–1798.
   PubMed Web of Science ®Google Scholar
• Thun, M. J., Day-Lally, C., Myers, D. G., Calle, E. E., Flanders, W. D., Zhu, B. -P., Namboodiri, M. M., and Heath, C. W.Jr., 1997. Trends in tobacco smoking and mortality from cigarette use in cancer prevention studies I (1959 through 1965) and II (1982 through 1988). In Changes in cigarette-related disease risks and their implications for prevention and control, eds. D. R. Shopland, , D. M. Burns, , L. Garfinkel, and J. M. Samet, pp.305–382. Smoking and Tobacco Control. Monograph No. 8 (NIH Pub. No. 97-4213.) Rockville, MD: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute. http://cancercontrol.cancer.gov/tcrb/monographs/8/m8_4.pdf
   Google Scholar
• Thun, M. J., and Heath, C. W.Jr., 1997. Changes in mortality from smoking in two American Cancer Society prospective studies since 1959. Prev. Med. 26:422–426.
   PubMed Web of Science ®Google Scholar
• Tso, T. C. 1992. 9. Maturity, harvesting, and curing. In Production, physiology, and biochemistry of tobacco plant, pp. 105–124. Beltsville, MD: IDEALS, Inc.
   Google Scholar
• Vanscheeuwijck, P. M., Teredesai, A., Terpstra, P. M., Verbeeck, J., Kuhl, P., Gerstenberg, B., Gebel, S., and Carmines, E. L. 2002. Evaluation of the potential effects of ingredients added to cigarettes. Part 4: Subchronic inhalation toxicity. Food Chem. Toxicol. 40:113–131.
   PubMed Web of Science ®Google Scholar
• Viegi, G., Scognamiglio, A., Baldacci, S., Pistelli, F., and Carrozzi, L. 2001. Epidemiology of chronic obstructive pulmonary disease (COPD). Respiration 68:4–19.
   PubMed Web of Science ®Google Scholar
• Wald, N. J., and Watt, H. C. 1997. Prospective study of effect of switching from cigarettes to pipes or cigars on mortality from three smoking related diseases. Br. Med. J. 314:1860–1863.
   PubMed Web of Science ®Google Scholar
• Wayne, G. F., and Connolly, G. N. 2004. Application, function, and effects of menthol in cigarettes: A survey of tobacco industry documents. Nicotine Tobacco Res. 6(Suppl. 1):S43–S54.
   Google Scholar
• Wynder, E. L., and Hoffmann, D. 1963. Ein experimenteller Beitrag zur Tabakrauchkanzerogenese (An experimental contribution to tobacco smoke carcinogenesis). Dtsch. Med. Wochenschr. 88:623–628.
   PubMedGoogle Scholar